YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation | eLife
Tubule-Specific Mst1/2 Deficiency Induces CKD via YAP and Non-YAP Mechanisms | American Society of Nephrology
Frontiers | Safety Considerations in the Development of Hippo Pathway Inhibitors in Cancers
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms | Clinical and Translational Medicine | Full Text
Macrophage K63-Linked Ubiquitination of YAP Promotes Its Nuclear Localization and Exacerbates Atherosclerosis - ScienceDirect
Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase–mediated inhibitory phosphorylation of the transcriptional coactivator YAP - ScienceDirect
Tubule-Specific Mst1/2 Deficiency Induces CKD via YAP and Non-YAP Mechanisms | American Society of Nephrology
Wnt and Src signals converge on YAP‐TEAD to drive intestinal regeneration | The EMBO Journal
YAP-independent mechanotransduction drives breast cancer progression | Nature Communications
YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation | eLife
YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3 | Nature Communications
CAPS Yap - Apps on Google Play
IJMS | Free Full-Text | The Ambivalent Function of YAP in Apoptosis and Cancer | HTML
YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation | eLife
Identification of cell context-dependent YAP-associated proteins reveals β1 and β4 integrin mediate YAP translocation independently of cell spreading | Scientific Reports
YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation | bioRxiv